{"id":51626,"date":"2025-09-11T11:01:00","date_gmt":"2025-09-11T02:01:00","guid":{"rendered":"https:\/\/www.veeva.com\/jp\/?post_type=resources&#038;p=51626"},"modified":"2025-10-21T17:46:29","modified_gmt":"2025-10-21T08:46:29","slug":"iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes","status":"publish","type":"resources","link":"https:\/\/www.veeva.com\/jp\/resources\/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes\/","title":{"rendered":"IQVIA \u3068 Veeva\u3001\u81e8\u5e8a\u958b\u767a\u304a\u3088\u3073\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u5206\u91ce\u306b\u304a\u3051\u308b\u9577\u671f\u7684\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3068\u3059\u3079\u3066\u306e\u6cd5\u7684\u61f8\u6848\u4e8b\u9805\u306e\u89e3\u6c7a\u3092\u767a\u8868"},"content":{"rendered":"<p style=\"text-align: center;\">\u30b0\u30ed\u30fc\u30d0\u30eb\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u306b\u3088\u308a<br \/>\n\u9867\u5ba2\u306e\u81e8\u5e8a\u958b\u767a\u304a\u3088\u3073\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u696d\u52d9\u306e\u52b9\u7387\u6027\u3068\u6709\u52b9\u6027\u3092\u5411\u4e0a<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: right;\">2025 \u5e74 9 \u6708 11 \u65e5<br \/>\nVeeva Japan \u682a\u5f0f\u4f1a\u793e<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.iqvia.com\/\" rel=\"noopener nofollow\" target=\"_blank\">IQVIA<\/a>\u3010 NYSE: IQV \u3011\u304a\u3088\u3073 <a href=\"https:\/\/www.veeva.com\/\" target=\"_blank\" rel=\"noopener nofollow\">Veeva Systems<\/a>\u3010 NYSE: VEEV \u3011\uff08\u672c\u793e\uff1a\u7c73\u56fd\u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e\uff1a\u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79\uff1a\u30af\u30ea\u30b9\u30fb\u30c0\u30a4\u30a2\u30e2\u30f3\u30c9\u3001\u4ee5\u4e0b Veeva \uff09\u306f\u3001\u81e8\u5e8a\u958b\u767a\u304a\u3088\u3073\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u5206\u91ce\u306b\u304a\u3051\u308b\u30b0\u30ed\u30fc\u30d0\u30eb\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3092\u7de0\u7d50\u3057\u3001\u3059\u3079\u3066\u306e\u6cd5\u7684\u61f8\u6848\u4e8b\u9805\u306e\u89e3\u6c7a\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u9577\u671f\u7684\u306a\u5951\u7d04\u3092\u901a\u3058\u3066\u3001\u9867\u5ba2\u306f Veeva \u3068 IQVIA \u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3001\u30c7\u30fc\u30bf\u3001\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3001\u30b5\u30fc\u30d3\u30b9\u3092\u3001\u30b7\u30f3\u30d7\u30eb\u3067\u52b9\u7387\u7684\u306b\u7d44\u307f\u5408\u308f\u305b\u3066\u5229\u7528\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\uff08\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001Veeva \u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f<a href=\"https:\/\/www.veeva.com\/resources\/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes\/#\" rel=\"noopener nofollow\" target=\"_blank\">\u3053\u3061\u3089<\/a>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002\uff09<\/p>\n<p>\u4eca\u56de\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u306b\u3088\u308a\u3001\u4ee5\u4e0b\u306e\u4e3b\u8981\u5206\u91ce\u306b\u304a\u3044\u3066\u3001 IQVIA \u3068 Veeva \u3068\u306e\u9023\u643a\u304c\u5bb9\u6613\u306b\u306a\u308a\u307e\u3059\u3002<\/p>\n<ul>\n<li><strong>\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u5206\u91ce\uff1a<\/strong>\u4e21\u793e\u306f\u3001\u30de\u30b9\u30bf\u30fc\u30c7\u30fc\u30bf\u3068\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u306e\u7b2c\u4e09\u8005\u30a2\u30af\u30bb\u30b9\uff08 TPA \uff09\u306b\u95a2\u3059\u308b\u5951\u7d04\u3092\u7de0\u7d50\u3001\u9867\u5ba2\u74b0\u5883\u306b\u304a\u3044\u3066\u3001\u4e21\u793e\u306e\u30c7\u30fc\u30bf\u3092\u3001\u9867\u5ba2\u304c\u5229\u7528\u3059\u308b\u76f8\u4e92\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3084\u30b5\u30fc\u30d3\u30b9\u3067\u6d3b\u7528\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3057\u305f\u3002\u5177\u4f53\u7684\u306b\u306f\u3001Veeva Network \u3067\u306e\u30de\u30b9\u30bf\u30fc\u30c7\u30fc\u30bf\u7ba1\u7406\uff08 MDM \uff09\u3001 Veeva Nitro \u3067\u306e\u5206\u6790\u3001 Veeva AI \u3067 IQVIA \u306e\u30c7\u30fc\u30bf\u304c\u5229\u7528\u53ef\u80fd\u306b\u306a\u308a\u307e\u3059\u3002\u307e\u305f\u3001 IQVIA \u306e\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u88fd\u54c1\u30fb\u30b5\u30fc\u30d3\u30b9\u3067\u306e Veeva \u30c7\u30fc\u30bf\u306e\u5229\u7528\u306b\u52a0\u3048\u3001 Veeva \u306e\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3001 AI \u3001Services Partner Programs \u306b\u53c2\u52a0\u3057\u3001\u540c\u793e\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3068 IQVIA Analytics\u3001 IQVIA Information Management\uff08 MDM \u3092\u542b\u3080\uff09\u3001IQVIA Agentic AI \u3001 IQVIA Commercial Orchestration \u3068\u3044\u3063\u305f\u5404\u88fd\u54c1\u30fb\u30b5\u30fc\u30d3\u30b9\u3068\u306e\u7d71\u5408\u3092\u652f\u63f4\u3057\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3068\u5305\u62ec\u7684\u306a\u30de\u30b9\u30bf\u30fc\u5951\u7d04\u306b\u3088\u308a\u3001\u9867\u5ba2\u306f\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u306b\u304a\u3051\u308b TPA \u53d6\u5f97\u30d7\u30ed\u30bb\u30b9\u3092\u8fc5\u901f\u304b\u3064\u5bb9\u6613\u306b\u9032\u3081\u3089\u308c\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002<\/li>\n<li><strong>\u81e8\u5e8a\u958b\u767a\u5206\u91ce\uff1a<\/strong> IQVIA \u306f\u3001Veeva \u306e CRO Clinical Data Partner \u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u53c2\u52a0\u3057\u3001 Veeva Clinical Suite \u3092\u6d3b\u7528\u3059\u308b\u3053\u3068\u3067\u3001 Veeva EDC \u306b\u3088\u308b\u30b9\u30bf\u30c7\u30a3\u69cb\u7bc9\u3082\u542b\u3081\u3001\u540c\u793e\u306e\u30bd\u30d5\u30c8\u30a6\u30a8\u30a2\u88fd\u54c1\u3092\u7528\u3044\u305f\u81e8\u5e8a\u8a66\u9a13\u306e\u5b9f\u65bd\u304c\u53ef\u80fd\u306b\u306a\u308a\u307e\u3057\u305f\u3002\u3053\u306e\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u306b\u3088\u308a\u3001\u9867\u5ba2\u306f IQVIA \u306e\u30af\u30ea\u30cb\u30ab\u30eb\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u3001\u30af\u30ea\u30cb\u30ab\u30eb\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3001\u305d\u3057\u3066 EDC \u30d7\u30ed\u30b0\u30e9\u30df\u30f3\u30b0\u306b\u95a2\u3059\u308b\u5c02\u9580\u77e5\u8b58\u3092\u3001 Veeva \u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3068\u7d44\u307f\u5408\u308f\u305b\u308b\u3053\u3068\u3067\u3001\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u69cb\u7bc9\u3001\u30b9\u30bf\u30c7\u30a3\u30ed\u30c3\u30af\u3001\u30c7\u30fc\u30bf\u30c7\u30ea\u30d0\u30ea\u30fc\u3068\u3044\u3063\u305f\u30d7\u30ed\u30bb\u30b9\u3092\u52a0\u901f\u3055\u305b\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002<\/li>\n<\/ul>\n<p>Veeva \u306e\u5275\u696d\u8005\u517c CEO \u3067\u3042\u308b Peter Gassner \u306f\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300cIQVIA \u3068\u306e\u88fd\u54c1\u30fb\u30b5\u30fc\u30d3\u30b9\u306e\u7d71\u5408\u3092\u5186\u6ed1\u306b\u9032\u3081\u308b\u3053\u3068\u3067\u3001\u5171\u901a\u306e\u9867\u5ba2\u3068\u696d\u754c\u5168\u4f53\u306b\u8ca2\u732e\u3059\u308b\u3053\u3068\u3092\u304a\u7d04\u675f\u3057\u307e\u3059\u3002\u4eca\u56de\u306e\u81e8\u5e8a\u958b\u767a\u3068\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u5206\u91ce\u3067\u306e\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u304c\u3001\u9867\u5ba2\u306b\u5927\u304d\u306a\u4fa1\u5024\u3092\u3082\u305f\u3089\u3059\u3053\u3068\u3092\u697d\u3057\u307f\u306b\u3057\u3066\u3044\u307e\u3059\u3002\u300d<\/p>\n<p>IQVIA \u306e\u4f1a\u9577\u517c CEO \u3067\u3042\u308b Ari Bousbib \u6c0f\u306f\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c IQVIA \u3068 Veeva \u306e\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u306f\u3001\u4e21\u793e\u306e\u9867\u5ba2\u306b\u3068\u3063\u3066\u3001\u60c5\u5831\u3001 AI \u3001\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3001\u30b5\u30fc\u30d3\u30b9\u306b\u304a\u3051\u308b\u6700\u9ad8\u6c34\u6e96\u306e\u30b1\u30a4\u30d1\u30d3\u30ea\u30c6\u30a3\u3092\u7d50\u96c6\u3059\u308b\u3082\u306e\u3067\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u3001  IQVIA \u306e\u9867\u5ba2\u306f Veeva \u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u4e0a\u3067\u81e8\u5e8a\u958b\u767a\u3092\u52a0\u901f\u3057\u3001\u6cbb\u7642\u85ac\u3092\u3088\u308a\u52b9\u7387\u7684\u306b\u5e02\u5834\u306b\u6295\u5165\u3057\u3001\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3078\u306e\u60a3\u8005\u30a2\u30af\u30bb\u30b9\u3092\u5411\u4e0a\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002\u300d<\/p>\n<p>\u8a73\u7d30\u306b\u3064\u3044\u3066\u306f\u3001iqvia.com\u306e<a href=\"https:\/\/www.iqvia.com\/solutions\/technologies\/partner-programs\/iqvia-and-veeva-clinical-and-commercial-partnerships\">Veeva Partnerships<\/a>\u307e\u305f\u306fveeva.com\u306e<a href=\"https:\/\/www.veeva.com\/iqvia\/\">IQVIA Partnerships<\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p><strong>IQVIA \u306b\u3064\u3044\u3066<\/strong><br \/>\nIQVIA\uff08 NYSE\uff1aIQV \uff09\u306f\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u304a\u3088\u3073\u30d8\u30eb\u30b9\u30b1\u30a2\u696d\u754c\u306b\u5bfe\u3057\u3001\u30af\u30ea\u30cb\u30ab\u30eb\u7814\u7a76\u30b5\u30fc\u30d3\u30b9\u3001\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u30a4\u30f3\u30b5\u30a4\u30c8\u3001\u30d8\u30eb\u30b9\u30b1\u30a2\u30a4\u30f3\u30c6\u30ea\u30b8\u30a7\u30f3\u30b9\u3092\u63d0\u4f9b\u3059\u308b\u4e16\u754c\u3092\u30ea\u30fc\u30c9\u3059\u308b\u30d7\u30ed\u30d0\u30a4\u30c0\u30fc\u3067\u3059\u3002IQVIA \u306e\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u306f\u3001IQVIA Connected Intelligence<sup>&#x2122;<\/sup> \u3092\u57fa\u76e4\u3068\u3057\u3001\u9ad8\u54c1\u8cea\u306a\u30d8\u30eb\u30b9\u30b1\u30a2\u30c7\u30fc\u30bf\u3001Healthcare-grade AI<sup>&reg;<\/sup>\u3001\u9ad8\u5ea6\u306a\u5206\u6790\u3001\u6700\u65b0\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3001\u304a\u3088\u3073\u5e83\u7bc4\u306a\u30c9\u30e1\u30a4\u30f3\u5c02\u9580\u77e5\u8b58\u306b\u57fa\u3065\u3044\u3066\u69cb\u7bc9\u3055\u308c\u305f\u5b9f\u7528\u7684\u306a\u30a4\u30f3\u30b5\u30a4\u30c8\u3068\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002IQVIA \u306f\u3001AI \u306e\u8cac\u4efb\u3042\u308b\u5229\u7528\u306b\u30b3\u30df\u30c3\u30c8\u3057\u3066\u304a\u308a\u3001\u30d7\u30e9\u30a4\u30d0\u30b7\u30fc\u3001\u898f\u5236\u9075\u5b88\u3001\u60a3\u8005\u306e\u5b89\u5168\u6027\u306b\u95a2\u3059\u308b\u6700\u9ad8\u6c34\u6e96\u306e\u30a2\u30d7\u30ed\u30fc\u30c1\u306b\u57fa\u3065\u3044\u3066\u69cb\u7bc9\u3055\u308c\u305fAI \u6d3b\u7528\u6a5f\u80fd\u306b\u3088\u308a\u3001\u696d\u754c\u304c\u6c42\u3081\u308b\u9ad8\u3044\u4fe1\u983c\u6027\u3001\u30b9\u30b1\u30fc\u30e9\u30d3\u30ea\u30c6\u30a3\u3001\u7cbe\u5ea6\u306e\u57fa\u6e96\u3092\u6e80\u305f\u3059AI\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u30d8\u30eb\u30b9\u30b1\u30a2\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u3001\u30c7\u30fc\u30bf\u30b5\u30a4\u30a8\u30f3\u30b9\u3001\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3001\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30ca\u30eb\u30fb\u30a8\u30af\u30bb\u30ec\u30f3\u30b9\u306e\u5c02\u9580\u5bb6\u3092\u542b\u3080\u3001100 \u30ab\u56fd\u4ee5\u4e0a\u306b\u308f\u305f\u308b\u7d04 89,000 \u4eba\u306e\u5f93\u696d\u54e1\u3092\u64c1\u3059\u308b IQVIA \u306f\u3001\u60a3\u8005\u306e\u30a2\u30a6\u30c8\u30ab\u30e0\u3068\u4e16\u754c\u4e2d\u306e\u4eba\u3005\u306e\u5065\u5eb7\u306e\u6539\u5584\u306b\u8ca2\u732e\u3059\u308b\u305f\u3081\u3001\u9769\u65b0\u7684\u306a\u533b\u7642\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u3068\u5546\u696d\u5316\u3092\u52a0\u901f\u3059\u308b\u3053\u3068\u306b\u5c3d\u529b\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>IQVIA \u306f\u3001\u60a3\u8005\u500b\u4eba\u306e\u30d7\u30e9\u30a4\u30d0\u30b7\u30fc\u4fdd\u8b77\u306b\u304a\u3051\u308b\u4e16\u754c\u7684\u306a\u30ea\u30fc\u30c0\u30fc\u3067\u3059\u3002\u540c\u793e\u306f\u3001\u500b\u4eba\u306e\u30d7\u30e9\u30a4\u30d0\u30b7\u30fc\u3092\u4fdd\u8b77\u3057\u3064\u3064\u3001\u533b\u7642\u95a2\u4fc2\u8005\u304c\u75be\u60a3\u30d1\u30bf\u30fc\u30f3\u3092\u7279\u5b9a\u3057\u3001\u3088\u308a\u826f\u3044\u6210\u679c\u306b\u5fc5\u8981\u306a\u7684\u78ba\u306a\u6cbb\u7642\u7d4c\u8def\u3084\u6cbb\u7642\u6cd5\u3068\u95a2\u9023\u4ed8\u3051\u308b\u306e\u306b\u5f79\u7acb\u3064\u898f\u6a21\u3067\u60c5\u5831\u3092\u751f\u6210\u30fb\u5206\u6790\u3059\u308b\u305f\u3081\u306b\u3001\u591a\u7a2e\u591a\u69d8\u306a\u30d7\u30e9\u30a4\u30d0\u30b7\u30fc\u5f37\u5316\u6280\u8853\u3068\u5b89\u5168\u5bfe\u7b56\u3092\u6d3b\u7528\u3057\u3066\u3044\u307e\u3059\u3002IQVIA \u306e\u77e5\u898b\u3068\u5b9f\u884c\u80fd\u529b\u306f\u3001\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3001\u533b\u7642\u6a5f\u5668\u4f01\u696d\u3001\u88fd\u85ac\u4f01\u696d\u3001\u533b\u5b66\u7814\u7a76\u8005\u3001\u653f\u5e9c\u6a5f\u95a2\u3001\u652f\u6255\u8005\u3001\u305d\u306e\u4ed6\u306e\u30d8\u30eb\u30b9\u30b1\u30a2\u95a2\u4fc2\u8005\u304c\u3001\u6cbb\u7642\u6cd5\u767a\u898b\u3078\u306e\u9053\u3092\u524d\u9032\u3055\u305b\u308b\u3079\u304f\u3001\u75be\u60a3\u3001\u4eba\u9593\u306e\u884c\u52d5\u3001\u79d1\u5b66\u7684\u9032\u6b69\u306b\u3064\u3044\u3066\u3088\u308a\u6df1\u3044\u7406\u89e3\u3092\u5f97\u308b\u3053\u3068\u3092\u652f\u63f4\u3057\u307e\u3059\u3002\u8a73\u7d30\u306b\u3064\u3044\u3066\u306f\u3001<a href=\"http:\/\/www.iqvia.com\/\" rel=\"noopener nofollow\" target=\"_blank\">www.iqvia.com<\/a> \u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p><strong>\u3010\u8ffd\u52a0\u60c5\u5831\u3011<\/strong><br \/>\nLinkedIn \u3067 Veeva \u306e\u60c5\u5831\u3092\u53d7\u3051\u53d6\u308b\u5834\u5408\u306f\u3053\u3061\u3089\uff1a<a href=\"https:\/\/www.linkedin.com\/company\/veeva-japan\/\" rel=\"noopener nofollow\" target=\"_blank\">jp.linkedin.com\/company\/veeva-japan<\/a><\/p>\n<p><strong>\u3010Veeva Systems \u793e\u306b\u3064\u3044\u3066\u3011<\/strong><br \/>\nVeeva\u306f\u3001\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3001\u30c7\u30fc\u30bf\u3001\u30d3\u30b8\u30cd\u30b9\u30b3\u30f3\u30b5\u30eb\u30c6\u30a3\u30f3\u30b0\u3092\u901a\u3058\u3066\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306b\u7279\u5316\u3057\u305f\u30af\u30e9\u30a6\u30c9\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3001\u512a\u308c\u305f\u88fd\u54c1\u3001\u9867\u5ba2\u306e\u6210\u529f\u306b\u5c3d\u529b\u3057\u3001\u4e16\u754c\u6700\u5927\u306e\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u304b\u3089\u65b0\u8208\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u307e\u3067\u30011,500\u793e\u4ee5\u4e0a\u306b\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001<a href=\"https:\/\/www.veeva.com\/jp\/pbc\/\">\u30d1\u30d6\u30ea\u30c3\u30af\u30fb\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u30fb\u30b3\u30fc\u30dd\u30ec\u30fc\u30b7\u30e7\u30f3<\/a>\u3068\u3057\u3066\u3001\u304a\u5ba2\u69d8\u3084\u5f93\u696d\u54e1\u3001\u682a\u4e3b\u3001\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3059\u308b\u696d\u754c\u3092\u542b\u3080\u3001\u3059\u3079\u3066\u306e\u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc\u306e\u5229\u76ca\u30d0\u30e9\u30f3\u30b9\u3092\u53d6\u308b\u3053\u3068\u306b\u53d6\u308a\u7d44\u3093\u3067\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001<a href=\"https:\/\/www.veeva.com\/jp\/\">www.veeva.com\/jp\/<\/a> \u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p><strong>\u3010Veeva Forward-looking Statements\u3011<\/strong><br \/>\nThis release contains forward-looking statements regarding the expected results and benefits from Veeva&#8217;s partnerships with IQVIA. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements.<\/p>\n<p class=\"text-center\">###<\/p>\n<p><strong>\u3010\u5831\u9053\u95a2\u4fc2\u8005\u304b\u3089\u306e\u304a\u554f\u5408\u305b\u5148\u3011<\/strong><br \/>\nVeeva Japan\u682a\u5f0f\u4f1a\u793e<br \/>\n\u5e83\u5831\u30c1\u30fc\u30e0<br \/>\n<a href=\"mailto:pr.jp@veeva.com\">pr.jp@veeva.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u9867\u5ba2\u306e\u81e8\u5e8a\u958b\u767a\u304a\u3088\u3073\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u696d\u52d9\u306e\u52b9\u7387\u6027\u3068\u6709\u52b9\u6027\u3092\u5411\u4e0a<\/p>\n","protected":false},"featured_media":51121,"parent":0,"template":"","class_list":["post-51626","resources","type-resources","status-publish","has-post-thumbnail","hentry","resource-type-press-release"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO Pro 5.0.1 - aioseo.com -->\n\t<meta name=\"robots\" content=\"max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.veeva.com\/jp\/resources\/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO Pro (AIOSEO) 5.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"ja_JP\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Veeva Japan\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"IQVIA \u3068 Veeva\u3001\u81e8\u5e8a\u958b\u767a\u304a\u3088\u3073\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u5206\u91ce\u306b\u304a\u3051\u308b\u9577\u671f\u7684\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3068\u3059\u3079\u3066\u306e\u6cd5\u7684\u61f8\u6848\u4e8b\u9805\u306e\u89e3\u6c7a\u3092\u767a\u8868 | Veeva Japan\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.veeva.com\/jp\/resources\/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.veeva.com\/jp\/wp-content\/uploads\/2025\/05\/resource-tile-news-340x240@2x.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.veeva.com\/jp\/wp-content\/uploads\/2025\/05\/resource-tile-news-340x240@2x.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"680\" \/>\n\t\t<meta property=\"og:image:height\" content=\"480\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2025-09-11T02:01:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2025-10-21T08:46:29+00:00\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp#listItem\",\"position\":1,\"name\":\"\\u30db\\u30fc\\u30e0\",\"item\":\"https:\\\/\\\/www.veeva.com\\\/jp\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/#listItem\",\"name\":\"\\u30ea\\u30bd\\u30fc\\u30b9\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/#listItem\",\"position\":2,\"name\":\"\\u30ea\\u30bd\\u30fc\\u30b9\",\"item\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resource-type\\\/press-release\\\/#listItem\",\"name\":\"\\u30d7\\u30ec\\u30b9\\u30ea\\u30ea\\u30fc\\u30b9\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp#listItem\",\"name\":\"\\u30db\\u30fc\\u30e0\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resource-type\\\/press-release\\\/#listItem\",\"position\":3,\"name\":\"\\u30d7\\u30ec\\u30b9\\u30ea\\u30ea\\u30fc\\u30b9\",\"item\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resource-type\\\/press-release\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes\\\/#listItem\",\"name\":\"IQVIA \\u3068 Veeva\\u3001\\u81e8\\u5e8a\\u958b\\u767a\\u304a\\u3088\\u3073\\u30b3\\u30de\\u30fc\\u30b7\\u30e3\\u30eb\\u5206\\u91ce\\u306b\\u304a\\u3051\\u308b\\u9577\\u671f\\u7684\\u30d1\\u30fc\\u30c8\\u30ca\\u30fc\\u30b7\\u30c3\\u30d7\\u3068\\u3059\\u3079\\u3066\\u306e\\u6cd5\\u7684\\u61f8\\u6848\\u4e8b\\u9805\\u306e\\u89e3\\u6c7a\\u3092\\u767a\\u8868\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/#listItem\",\"name\":\"\\u30ea\\u30bd\\u30fc\\u30b9\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes\\\/#listItem\",\"position\":4,\"name\":\"IQVIA \\u3068 Veeva\\u3001\\u81e8\\u5e8a\\u958b\\u767a\\u304a\\u3088\\u3073\\u30b3\\u30de\\u30fc\\u30b7\\u30e3\\u30eb\\u5206\\u91ce\\u306b\\u304a\\u3051\\u308b\\u9577\\u671f\\u7684\\u30d1\\u30fc\\u30c8\\u30ca\\u30fc\\u30b7\\u30c3\\u30d7\\u3068\\u3059\\u3079\\u3066\\u306e\\u6cd5\\u7684\\u61f8\\u6848\\u4e8b\\u9805\\u306e\\u89e3\\u6c7a\\u3092\\u767a\\u8868\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resource-type\\\/press-release\\\/#listItem\",\"name\":\"\\u30d7\\u30ec\\u30b9\\u30ea\\u30ea\\u30fc\\u30b9\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/#organization\",\"name\":\"Veeva Systems Japan\",\"description\":\"The Industry Cloud for Life Sciences\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/\",\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/veeva-japan\\\/\"]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes\\\/#webpage\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes\\\/\",\"name\":\"IQVIA \\u3068 Veeva\\u3001\\u81e8\\u5e8a\\u958b\\u767a\\u304a\\u3088\\u3073\\u30b3\\u30de\\u30fc\\u30b7\\u30e3\\u30eb\\u5206\\u91ce\\u306b\\u304a\\u3051\\u308b\\u9577\\u671f\\u7684\\u30d1\\u30fc\\u30c8\\u30ca\\u30fc\\u30b7\\u30c3\\u30d7\\u3068\\u3059\\u3079\\u3066\\u306e\\u6cd5\\u7684\\u61f8\\u6848\\u4e8b\\u9805\\u306e\\u89e3\\u6c7a\\u3092\\u767a\\u8868 | Veeva Japan\",\"inLanguage\":\"ja\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes\\\/#breadcrumblist\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/resource-tile-news-340x240@2x.png\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes\\\/#mainImage\",\"width\":680,\"height\":480,\"caption\":\"resource tile news 340x240@2x\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes\\\/#mainImage\"},\"datePublished\":\"2025-09-11T11:01:00+09:00\",\"dateModified\":\"2025-10-21T17:46:29+09:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/#website\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/\",\"name\":\"Veeva Japan\",\"description\":\"The Industry Cloud for Life Sciences\",\"inLanguage\":\"ja\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO Pro -->\r\n\t\t<title>IQVIA \u3068 Veeva\u3001\u81e8\u5e8a\u958b\u767a\u304a\u3088\u3073\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u5206\u91ce\u306b\u304a\u3051\u308b\u9577\u671f\u7684\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3068\u3059\u3079\u3066\u306e\u6cd5\u7684\u61f8\u6848\u4e8b\u9805\u306e\u89e3\u6c7a\u3092\u767a\u8868 | Veeva Japan<\/title>\n\n","aioseo_head_json":{"title":"IQVIA \u3068 Veeva\u3001\u81e8\u5e8a\u958b\u767a\u304a\u3088\u3073\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u5206\u91ce\u306b\u304a\u3051\u308b\u9577\u671f\u7684\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3068\u3059\u3079\u3066\u306e\u6cd5\u7684\u61f8\u6848\u4e8b\u9805\u306e\u89e3\u6c7a\u3092\u767a\u8868 | Veeva Japan","description":"","canonical_url":"https:\/\/www.veeva.com\/jp\/resources\/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes\/","robots":"max-snippet:-1, max-image-preview:large, max-video-preview:-1","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.veeva.com\/jp\/resources\/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp#listItem","position":1,"name":"\u30db\u30fc\u30e0","item":"https:\/\/www.veeva.com\/jp","nextItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp\/resources\/#listItem","name":"\u30ea\u30bd\u30fc\u30b9"}},{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp\/resources\/#listItem","position":2,"name":"\u30ea\u30bd\u30fc\u30b9","item":"https:\/\/www.veeva.com\/jp\/resources\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp\/resource-type\/press-release\/#listItem","name":"\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp#listItem","name":"\u30db\u30fc\u30e0"}},{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp\/resource-type\/press-release\/#listItem","position":3,"name":"\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9","item":"https:\/\/www.veeva.com\/jp\/resource-type\/press-release\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp\/resources\/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes\/#listItem","name":"IQVIA \u3068 Veeva\u3001\u81e8\u5e8a\u958b\u767a\u304a\u3088\u3073\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u5206\u91ce\u306b\u304a\u3051\u308b\u9577\u671f\u7684\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3068\u3059\u3079\u3066\u306e\u6cd5\u7684\u61f8\u6848\u4e8b\u9805\u306e\u89e3\u6c7a\u3092\u767a\u8868"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp\/resources\/#listItem","name":"\u30ea\u30bd\u30fc\u30b9"}},{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp\/resources\/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes\/#listItem","position":4,"name":"IQVIA \u3068 Veeva\u3001\u81e8\u5e8a\u958b\u767a\u304a\u3088\u3073\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u5206\u91ce\u306b\u304a\u3051\u308b\u9577\u671f\u7684\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3068\u3059\u3079\u3066\u306e\u6cd5\u7684\u61f8\u6848\u4e8b\u9805\u306e\u89e3\u6c7a\u3092\u767a\u8868","previousItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp\/resource-type\/press-release\/#listItem","name":"\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9"}}]},{"@type":"Organization","@id":"https:\/\/www.veeva.com\/jp\/#organization","name":"Veeva Systems Japan","description":"The Industry Cloud for Life Sciences","url":"https:\/\/www.veeva.com\/jp\/","sameAs":["https:\/\/www.linkedin.com\/company\/veeva-japan\/"]},{"@type":"WebPage","@id":"https:\/\/www.veeva.com\/jp\/resources\/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes\/#webpage","url":"https:\/\/www.veeva.com\/jp\/resources\/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes\/","name":"IQVIA \u3068 Veeva\u3001\u81e8\u5e8a\u958b\u767a\u304a\u3088\u3073\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u5206\u91ce\u306b\u304a\u3051\u308b\u9577\u671f\u7684\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3068\u3059\u3079\u3066\u306e\u6cd5\u7684\u61f8\u6848\u4e8b\u9805\u306e\u89e3\u6c7a\u3092\u767a\u8868 | Veeva Japan","inLanguage":"ja","isPartOf":{"@id":"https:\/\/www.veeva.com\/jp\/#website"},"breadcrumb":{"@id":"https:\/\/www.veeva.com\/jp\/resources\/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes\/#breadcrumblist"},"image":{"@type":"ImageObject","url":"https:\/\/www.veeva.com\/jp\/wp-content\/uploads\/2025\/05\/resource-tile-news-340x240@2x.png","@id":"https:\/\/www.veeva.com\/jp\/resources\/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes\/#mainImage","width":680,"height":480,"caption":"resource tile news 340x240@2x"},"primaryImageOfPage":{"@id":"https:\/\/www.veeva.com\/jp\/resources\/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes\/#mainImage"},"datePublished":"2025-09-11T11:01:00+09:00","dateModified":"2025-10-21T17:46:29+09:00"},{"@type":"WebSite","@id":"https:\/\/www.veeva.com\/jp\/#website","url":"https:\/\/www.veeva.com\/jp\/","name":"Veeva Japan","description":"The Industry Cloud for Life Sciences","inLanguage":"ja","publisher":{"@id":"https:\/\/www.veeva.com\/jp\/#organization"}}]},"og:locale":"ja_JP","og:site_name":"Veeva Japan","og:type":"article","og:title":"IQVIA \u3068 Veeva\u3001\u81e8\u5e8a\u958b\u767a\u304a\u3088\u3073\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u5206\u91ce\u306b\u304a\u3051\u308b\u9577\u671f\u7684\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3068\u3059\u3079\u3066\u306e\u6cd5\u7684\u61f8\u6848\u4e8b\u9805\u306e\u89e3\u6c7a\u3092\u767a\u8868 | Veeva Japan","og:url":"https:\/\/www.veeva.com\/jp\/resources\/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes\/","og:image":"https:\/\/www.veeva.com\/jp\/wp-content\/uploads\/2025\/05\/resource-tile-news-340x240@2x.png","og:image:secure_url":"https:\/\/www.veeva.com\/jp\/wp-content\/uploads\/2025\/05\/resource-tile-news-340x240@2x.png","og:image:width":680,"og:image:height":480,"article:published_time":"2025-09-11T02:01:00+00:00","article:modified_time":"2025-10-21T08:46:29+00:00"},"aioseo_meta_data":{"post_id":"51626","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"limit_modified_date":false,"open_ai":"{\"title\":{\"suggestions\":[],\"usage\":0},\"description\":{\"suggestions\":[],\"usage\":0}}","created":"2025-08-28 05:43:37","updated":"2026-08-24 07:48:16","focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":"2026-08-22 15:51:12"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.veeva.com\/jp\" title=\"\u30db\u30fc\u30e0\">\u30db\u30fc\u30e0<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.veeva.com\/jp\/resources\/\" title=\"\u30ea\u30bd\u30fc\u30b9\">\u30ea\u30bd\u30fc\u30b9<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.veeva.com\/jp\/resource-type\/press-release\/\" title=\"\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9\">\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\tIQVIA \u3068 Veeva\u3001\u81e8\u5e8a\u958b\u767a\u304a\u3088\u3073\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u5206\u91ce\u306b\u304a\u3051\u308b\u9577\u671f\u7684\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3068\u3059\u3079\u3066\u306e\u6cd5\u7684\u61f8\u6848\u4e8b\u9805\u306e\u89e3\u6c7a\u3092\u767a\u8868\n<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"\u30db\u30fc\u30e0","link":"https:\/\/www.veeva.com\/jp"},{"label":"\u30ea\u30bd\u30fc\u30b9","link":"https:\/\/www.veeva.com\/jp\/resources\/"},{"label":"\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9","link":"https:\/\/www.veeva.com\/jp\/resource-type\/press-release\/"},{"label":"IQVIA \u3068 Veeva\u3001\u81e8\u5e8a\u958b\u767a\u304a\u3088\u3073\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u5206\u91ce\u306b\u304a\u3051\u308b\u9577\u671f\u7684\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3068\u3059\u3079\u3066\u306e\u6cd5\u7684\u61f8\u6848\u4e8b\u9805\u306e\u89e3\u6c7a\u3092\u767a\u8868","link":"https:\/\/www.veeva.com\/jp\/resources\/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes\/"}],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/resources\/51626","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/resources"}],"version-history":[{"count":2,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/resources\/51626\/revisions"}],"predecessor-version":[{"id":51627,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/resources\/51626\/revisions\/51627"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media\/51121"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=51626"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}